Roberto Galli

Roberto Galli is an accomplished finance professional with extensive experience in the biopharmaceutical sector. As Chief Financial Officer and Vice President Finance at Newron Pharmaceuticals SpA since November 2002, Galli plays a crucial role in the Senior Management Team, reporting directly to the CEO and participating in Board of Directors meetings. Previous responsibilities included serving as Finance Director, where oversight of accounting, tax, treasury, budgeting, and reporting functions was paramount, and as Controller, focusing on management accounting procedures and system development. Galli is also an active member of Italian Angels for Biotech since October 2015 and began their career as a Senior Auditor at Price Waterhouse Coopers, following a position as a Junior Controller at Reuters Italia. Galli holds a degree in Economics with a specialization in Accounting and Legal from Università Bocconi.

Location

Milan, Italy

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


IAB - Italian Angels for Biotech

IAB provides an environment that facilitates interactions between interesting start-up projects and its members. Our goal is to identify and nurture top talent entrepreneurs in the Life Sciences sector. We lead equity investments to help ideas and start-ups to reach key objectives. Our value is beyond financing, we do not provide just angel money. We bring mentoring and expertise to great ideas by becoming entrepreneur partners. Our added value is in networking: we connect start-ups with international venture capitals, Life Sciences experts, strategic partners, industry veterans as well as service providers such as law firms, as well as other advisors or service companies. We usually take board seats and work closely with entrepreneurs to maximize the chances of success.


Headquarters

Bresso, Italy

Employees

11-50

Links